APA (7th ed.) Citation

I, O., T, G., D, K., M, H., K, Y., S, K., . . . K, D. (2023). Targeted therapy using polymyxin B hemadsorption in patients with sepsis: A post-hoc analysis of the JSEPTIC-DIC study and the EUPHRATES trial. Critical care (London, England), 27(1), 245. https://doi.org/10.1186/s13054-023-04533-3

Chicago Style (17th ed.) Citation

I, Osawa, Goto T, Kudo D, Hayakawa M, Yamakawa K, Kushimoto S, Foster DM, Kellum JA, and Doi K. "Targeted Therapy Using Polymyxin B Hemadsorption in Patients with Sepsis: A Post-hoc Analysis of the JSEPTIC-DIC Study and the EUPHRATES Trial." Critical Care (London, England) 27, no. 1 (2023): 245. https://doi.org/10.1186/s13054-023-04533-3.

MLA (9th ed.) Citation

I, Osawa, et al. "Targeted Therapy Using Polymyxin B Hemadsorption in Patients with Sepsis: A Post-hoc Analysis of the JSEPTIC-DIC Study and the EUPHRATES Trial." Critical Care (London, England), vol. 27, no. 1, 2023, p. 245, https://doi.org/10.1186/s13054-023-04533-3.